News
Mar. 23, 2016
MimiClon®, Inc. Receives FDA Clearance for Concurrent Use of its Wound Management Devices
Columbia, MD – (March 23, 2016) – MimiClon, Inc. today announced that it has received additional FDA clearance for its Mimic Powder ® device, which describes the concurrent use of Mimic Powder ® in…
Jan. 20, 2016
MimiClon®, Inc. Signs Purchasing Agreement with HealthTrust
Columbia, Maryland – (January 20, 2016) – MimiClon, Inc., a regenerative medicine company focused on the development, manufacturing, and commercialization of tissue repair products, today announced that it has signed…
Jan. 11, 2016
MimiClon®, Inc. Names Patrick McBrayer Chief Executive Officer
Columbia, MD – (January 11, 2016) – MimiClon, Inc. today announced that it has named Patrick (Pat) McBrayer President and Chief Executive Officer. McBrayer succeeds Kyle Kerbawy, who will remain…
